Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress

MaryFran Sowers, Daniel McConnell, Mary L. Jannausch, John F. Randolph, Robert Brook, Ellen B Gold, Sybil Crawford, Bill Lasley

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Objective: Oestradiol (E2) and its metabolites 2-hydroxyoestrone (2-OHE1) and 16α-hydroxyoestrone (16α-OHE1) are thought to curtail the greater oxidative stress found in the development and progression of disease conditions including atherosclerosis. We related oestrogen levels to F 2a-isoprostane levels, a biomarker of oxidative stress. Design and participants: Data were obtained from 1647 women, aged 47-57 years, participating in the fifth annual follow-up of the Study of Women's Health Across the Nation (SWAN), a study of the menopausal transition. Measurements: Serum E2 and urinary 2-OHE1 and 16α-OHE1 concentrations were determined by enzyme-linked immunosorbent assay (ELISA) and urinary F2a- isoprostanes were measured by enzyme immunoassay (EIA). Results: F 2a-isoprostane concentrations were elevated in women who smoked, a behaviour associated with increased oxidative stress, but not in stages of the natural menopause. Mean F2a-isoprostane concentrations among pre- and postmenopausal women who smoked were 1082 and 1064 pg/ml, respectively, values double those in pre- (343 pg/ml) and postmenopausal (379 pg/ml) nonsmoking women. 2-OHE1 and F2a-isoprostane concentrations were positively and highly correlated (partial correlations ρY|X = 0.44 and ρY|X = 0.43 in pre- and postmenopausal women, respectively). Similarly, 16α-OHE1 concentrations were positively and highly correlated with F2a-isoprostane concentrations (ρY|X = 0.52 and ρY|X = 0.59 in pre- and postmenopausal women, respectively). E2 was significantly correlated with F2a-isoprostanes only in postmenopausal women (ρY|X = 0.20). Associations were adjusted for age, body mass index (BMI), race/ethnicity, lipids, physical activity level and alcohol consumption. Conclusions: This study does not support the commonly held hypothesis that levels of endogenous E2 or its oestrone metabolites favourably modify oxidative stress by decreasing F2a-isoprostane levels.

Original languageEnglish (US)
Pages (from-to)806-813
Number of pages8
JournalClinical Endocrinology
Volume68
Issue number5
DOIs
StatePublished - 2008

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress'. Together they form a unique fingerprint.

  • Cite this

    Sowers, M., McConnell, D., Jannausch, M. L., Randolph, J. F., Brook, R., Gold, E. B., Crawford, S., & Lasley, B. (2008). Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress. Clinical Endocrinology, 68(5), 806-813. https://doi.org/10.1111/j.1365-2265.2007.03108.x